The quarterly scientific journal

In the news

19/02/2024

Clean Cells, your partner for single cell cloning to cGMP cell banks

As a contract organization specializing in cGMP cell & virus banking and QC testing, Clean Cells knows the importance of qualitative cell line development. We thus implemented Solentim’s VIPS® PRO, a state-of-the-art single cell cloning platform to isolate potent clones and characterize the monoclonality of biotherapeutics producing cell lines, with an increased traceability as part of a regulatory compliant approach.

Read more
24/10/2023

Increasing biologics manufacturing capacities

With 23+ years of experience handling hundreds of cell and virus models, Clean Cells has positioned itself as a leader in cell and virus banking, providing complementary characterization and storage services. Our state-of-the-art cGMP facility launched earlier this year now welcomes our biologics manufacturing capacities, providing 8 new clean rooms designed for all types of biopharma projects and equiped to meet production specifications for both adherent and suspension cells.

Read more
Scale-XTM bioreactor
22/06/2023

Assessing the scale-X(TM) bioreactor’s biomanufacturing capacities on Vero cells

To further extend their biomanufacturing capabilities and cater to Univercells clients' growing needs, Naobios has recently conducted a comprehensive assessment of the performance of Vero cells cultured within the scale-X(TM) bioreactor provided by Univercells Technologies. This assessment aimed to evaluate the compatibility and efficiency of the Vero cell line in this novel bioreactor system for viral-based bioproduction.

Read more
03/05/2023

A new facility to extend biopharma services

  • Biosafety testing
  • cell banks
  • end-to-end
  • Facilities
  • Testing
  • virus banks

Last January, Clean Cells opened its new cGMP-compliant facility, a cutting-edge 5 300 m2 platform which considerably extends biopharma capacities. Additional biologics testing capacity, extended cell and gene therapy services, end-to-end biomanufacturing and storage: Clean Cells’ new site opens a new chapter in the company’s rich history.

Read more
06/12/2022

Characterization and control testing of lentiviral vectors and derived products

  • Gene Therapy
  • lentiviral vectors
  • RCL Pool assay

Clean Cells has partnered with customers on dozens of gene therapy projectsinvolving testing of lentiviral vectors and CAR-T cell therapies.

Read more
14/09/2022

Integrated solution for cell banking and characterization

  • Cell banking
  • Characterization
  • Master Cell Banks
  • MCB
  • Storage

Clean Cells offers an integrated solution for cell bank generation in GMP and non-GMP-settings together with full characterization services and additional long-term storage options to secure valuable material.

Read more
17/05/2022

GMP biomanufacturing in a BSL-3 suite

  • BSL3
  • Capabilities
  • Facilities
  • manufacturing

A GMP biomanufacturing expert, Naobios has worked with numerous viruses requiring specific biocontainment procedures. Our state-of-the-art BSL-3 suite welcomes hazardous microbes used for the generation of virus-based therapeutic products.

Read more
24/03/2022

Optimization and Validation of digital PCR assays

  • analytical development
  • assays
  • digital PCR
  • dPCR
  • PCR
  • QC
  • quality control

Following the implementation and qualification of a digital PCR platform, Clean Cells has completed optimization and validation work according to ICHQ2(R1) and 21CFR part 11 to support internal methods and culminating in full GMP compliance.

Read more